Biomarkers of oxidative stress associated with the risk of potentially malignant oral disorders

Anticancer Research

Volumn 38, Issue 9, 2018, Pages 5211-5216

  Senghore, Thomas ^a,b   Li, Yu Feng ^c   Sung, Fung Chang ^c   Tsai, Ming Hsui ^e   Hua, Chun Hung ^c   Liu, Chiu Shong ^c   Huang, Ru Jiun ^a   Yeh, Chih Ching ^a,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF THE GAMBIA   (Gambia)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e NONE

Author keywords

Biomarkers; Leukoplakia; Oxidative stress; Potentially malignant oral disorders

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; BIOLOGICAL MARKER; GENOMIC DNA; 8-EPI-PROSTAGLANDIN F2ALPHA; 8-OXO-7-HYDRODEOXYGUANOSINE; DEOXYGUANOSINE; PROSTAGLANDIN F2 ALPHA;

ADULT; ALCOHOL CONSUMPTION; ARECA NUT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPING TECHNIQUE; HUMAN; LEUKOPLAKIA; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MASTICATION; MEASUREMENT; MOUTH CANCER; OXIDATIVE STRESS; POTENTIALLY MALIGNANT ORAL DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ANALOGS AND DERIVATIVES; BLOOD; MIDDLE AGED; MOUTH TUMOR; PRECANCER;

ADULT; BIOMARKERS; DEOXYGUANOSINE; DINOPROST; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 85052990851     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.12844     Document Type: Article

References (28)

1. Su C-C, Tsai K-Y, Hsu Y-Y, Lin Y-Y and Lian I-B: Chronic exposure to heavy metals and risk of oral cancer in Taiwanese males. Oral Oncol 46(8): 586-590, 2010.
2. Swenberg JA, Lu K, Moeller BC, Gao L, Upton PB, Nakamura J and Starr TB: Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology, and risk assessment. Toxicol Sci 120(Suppl 1): S130-S145, 2011.
3. Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160(1): 1-40, 2006.
4. Marczynski B, Rozynek P, Kraus T, Schlosser S, Raithel HJ and Baur X: Levels of 8-hydroxy-2’-deoxyguanosine in DNA of white blood cells from workers highly exposed to asbestos in Germany. Mutat Res 468(2): 195-202, 2000.
5. Xing F, Li Z, Sun A and Xing D: Reactive oxygen species promote chloroplast dysfunction and salicylic acid accumulation in fumonisin B1-induced cell death. FEBS Lett 587(14): 2164-2172, 2013.
6. Thomson CA, Giuliano AR, Shaw JW, Rock CL, Ritenbaugh CK, Hakim IA, Hollenbach KA, Alberts DS and Pierce JP: Diet and biomarkers of oxidative damage in women previously treated for breast cancer. Nutr Cancer 51(2): 146-154, 2005.
7. Ma N, Tagawa T, Hiraku Y, Murata M, Ding X and Kawanishi S: 8-Nitroguanine formation in oral leukoplakia, a premalignant lesion. Nitric Oxide 14(2): 137-143, 2006.
8. Choudhari SK, Chaudhary M, Gadbail AR, Sharma A and Tekade S: Oxidative and antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncol 50(1): 10-18, 2014.
9. Sheweita SA: Drug-metabolizing enzymes: Mechanisms and functions. Curr Drug Metab 1(2): 107-132, 2000.
10. Sosa V, Moliné T, Somoza R, Paciucci R, Kondoh H and Lleonart ME: Oxidative stress and cancer: An overview. Ageing Res Rev 12(1): 376-390, 2013.
11. Li YF, Sung FC, Tsai MH, Hua CH, Liu CS, Huang YT and Yeh CC: Interactions between cigarette smoking and polymorphisms of xenobiotic-metabolizing genes: The risk of oral leukoplakia. Dis Markers 34(4): 247-255, 2013.
12. Kadashetti V, Shivakumar KM, Chaudhary M, Patil S, Gawande M and Hande A: Influence of risk factors on patients suffering from potentially malignant disorders and oral cancer: A case–control study. J Oral Maxillofac Pathol 21(3): 455-456, 2017.
13. Warnakulasuriya S, Johnson NW and van der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 36(10): 575-580, 2007.
14. Speight PM, Khurram SA and Kujan O: Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol 125(6): 612-627, 2017.
15. Chiang C-J, Lo W-C, Yang Y-W, You S-L, Chen C-J and Lai MS: Incidence and survival of adult cancer patients in Taiwan, 2002-2012. J Formos Med Assoc 115(12): 1076-1088, 2016.
16. Poulsen HE, Prieme H and Loft S: Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 7(1): 9-16, 1998.
17. Srivastava KC and Shrivastava D: Analysis of plasma lipid peroxidation and antioxidant enzymes status in patients of oral leukoplakia: A case–control study. J Int Soc Prev Community Dent 6(Suppl 3): S213-s218, 2016.
18. Ziech D, Franco R, Georgakilas AG, Georgakila S, Malamou-Mitsi V, Schoneveld O, Pappa A and Panayiotidis MI: The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. Chem Biol Interact 188(2): 334-339, 2010.
19. Kondo S, Toyokuni S, Tanaka T, Hiai H, Onodera H, Kasai H and Imamura M: Overexpression of the hOGG1 gene and high 8-hydroxy-2’-deoxyguanosine (8-OHdG) lyase activity in human colorectal carcinoma: Regulation mechanism of the 8-OHdG level in DNA. Clin Cancer Res 6(4): 1394-1400, 2000.
20. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE and Marnett LJ: Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278(33): 31426-31433, 2003.
21. Rossner P Jr., Gammon MD, Terry MB, Agrawal M, Zhang FF, Teitelbaum SL, Eng SM, Gaudet MM, Neugut AI and Santella RM: Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev 15(4): 639-644, 2006.
22. Brys M, Morel A, Forma E, Krzeslak A, Wilkosz J, Rozanski W and Olas B: Relationship of urinary isoprostanes to prostate cancer occurrence. Mol Cell Biochem 372(1-2): 149-153, 2013.
23. Freitas Bde J, Lloret GR, Visacri MB, Tuan BT, Amaral LS, Baldini D, de Sousa VM, de Castro LL, Aguiar JR, Pincinato Ede C, Mazzola PG and Moriel P: High 15-F2t-isoprostane levels in patients with a previous history of nonmelanoma skin cancer: The effects of supplementary antioxidant therapy. Biomed Res Int 2015: 963569, 2015.
24. Benamira M, Johnson K, Chaudhary A, Bruner K, Tibbetts C and Marnett LJ: Induction of mutations by replication of malondialdehyde modified M13 DNA in Escherichia coli: Determination of the extent of DNA modification, genetic requirements for mutagenesis, and types of mutations induced. Carcinogenesis 16(1): 93-99, 1995.
25. Liu H, Jia J, Mao X and Lin Z: Association of CYP1A1 and GSTM1 polymorphisms with oral cancer susceptibility: A meta-analysis. Medicine 94(27): e895, 2015.
26. Chole RH, Patil RN, Basak A, Palandurkar K and Bhowate R: Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. J Cancer Res Ther 6(4): 487-491, 2010.
27. Valko M, Jomova K, Rhodes CJ, Kuca K and Musilek K: Redox- and non-redox-metal-induced formation of free radicals and their role in human disease. Arch Toxicol 90(1): 1-37, 2016.
28. He P, Wei M, Wang Y and Liu Q: Associations among glutathione S-transferase T1, M1, and P1 polymorphisms and the risk of oral leukoplakia. Genet Test Mol Biomarkers 20(6): 312-321, 2016.